Comment: Enfortumab vedotin is an effective therapy and important development for urotherial cancer patients

Novel methods of drug testing and biopsy in India

Myeloma highlights from EHA 2019

AlloHCT conditioning intensity in AML in complete remission with residual disease

Inhibition of NADK strongly inhibits T-ALL cells from growing

Novel immunotherapy 5F9 plus rituximab well tolerated with rapid and durable responses in R/R DLBCL and indolent lymphoma

Imetelstat provides durable transfusion independence in heavily transfused non-del(5q) LR-MDS R/R to ESAS

Intervention for AML patients with MRD can result in improved survival

Carfilzomib and irinotecan in relapsed small cell lung cancer

Predictive models for treatment risk in cancer

OpenMRS: An online medical file system to replace paper in low to middle income countries

The Global Health Catalyst initiative